1. Antimicrobial potential of carvacrol against Edwardsiella piscicida in vitro.
- Author
-
Qin T, Dowah RGW, Chen K, Xi B, Pan L, and Xie J
- Subjects
- Animals, Virulence drug effects, Virulence Factors genetics, Enterobacteriaceae Infections microbiology, Enterobacteriaceae Infections drug therapy, Hemolysis drug effects, Quorum Sensing drug effects, Gene Expression Regulation, Bacterial drug effects, Monoterpenes pharmacology, Bacterial Adhesion drug effects, Cymenes pharmacology, Microbial Sensitivity Tests, Biofilms drug effects, Edwardsiella drug effects, Zebrafish, Anti-Bacterial Agents pharmacology, Fish Diseases microbiology, Fish Diseases drug therapy
- Abstract
With the alarming rise of antibiotic-resistant bacteria, novel antibacterial substances are urgently needed for controlling and treating multidrug-resistant bacterial infections. Edwardsiella piscicida is an important zoonotic enteric pathogen, that can cause systemic hemorrhagic septicemia in fish. Carvacrol, a major terpene of oregano essential oil, has a wide range of antibacterial activities. This study aimed to analyze the effect of carvacrol on the growth and virulence of E. piscicida in vitro. The minimum inhibitory concentration (MIC) of carvacrol against E. piscicida was 125 μg/mL. The sub-inhibitory concentrations of carvacrol significantly decreased the biofilm formation of E. piscicida in a dose dependent manner, whereas increased the hemolytic activity with a negative correlation. The quantitative real-time PCR results showed that carvacrol at sub-MICs downregulated the expression of related virulence genes, including flagellum (fimA, fliC, flgN), hemolysins (ethA, ethB), quorum sensing systems (luxR, qseB), T3SS (esrB, esrC) and T6SS (evpB, evpC). Moreover, carvacrol (≤1/8 MIC) reduced the cytotoxicity, adherence and internalization activities of E. piscicida to the EPC cells. In vivo trial, the diet mixed with carvacrol increased the survival of zebrafish infected with E. piscicida. Overall, these findings suggested that carvacrol might be a promising therapeutic agent against E. piscicida infection in aquaculture., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF